Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 65,626 | 64,495 | 78,527 | 23,496 | -6,685 |
| Depreciation Amortization | -6,245 | -4,730 | -2,454 | -1,103 | -2,938 |
| Accounts payable and accrued liabilities | 991 | -1,855 | -1,541 | -655 | -2,805 |
| Other Working Capital | -129,223 | -90,649 | -75,218 | -54,177 | 124,326 |
| Other Operating Activity | 27,294 | 22,787 | 15,000 | 6,920 | 27,905 |
| Operating Cash Flow | $-41,557 | $-9,952 | $14,314 | $-25,519 | $139,803 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,640 | -78,640 | 3,648 | 26,985 | -132,781 |
| PPE Investments | -3,158 | -2,523 | -1,884 | -838 | -5,614 |
| Investing Cash Flow | $-27,798 | $-81,163 | $1,764 | $26,147 | $-138,395 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 102,964 | 101,562 | 101,573 | 206 | 21,037 |
| Financing Cash Flow | $102,964 | $101,562 | $101,573 | $206 | $21,037 |
| Beginning Cash Position | 71,552 | 71,552 | 71,552 | 71,552 | 49,107 |
| End Cash Position | 105,161 | 81,999 | 189,203 | 72,386 | 71,552 |
| Net Cash Flow | $33,609 | $10,447 | $117,651 | $834 | $22,445 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,557 | -9,952 | 14,314 | -25,519 | 139,803 |
| Capital Expenditure | -3,158 | -2,523 | -1,884 | -838 | -5,614 |
| Free Cash Flow | -44,715 | -12,475 | 12,430 | -26,357 | 134,189 |